Strange slowdown in psilocybin treatment approvals in Canada, for no apparent reason. To date, 304 patients have received it since 2022, mainly for depression or anxiety related to the end of life.
Article in French (with a link to the original article in Nature): www.lapresse.ca/actualites/s...
